ARTICLE
27 March 2024

Holland & Knight Health Dose: March 19, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • FY 2024 Appropriations Update
  • House E&C Committee's Subcommittee on Health Holds Markup of Public Health Legislation; Full Committee Markup Scheduled
  • HHS Secretary Becerra Appears Before Senate Finance Committee
  • House W&M Committee Holds Field Hearing on Emergency Medical Care
  • MedPAC and MACPAC Release March Reports to Congress
  • Legislation Addressing 340B Reform Introduced in House
  • Senate HELP Committee Releases RFI on Regulation of Clinical Tests
  • FDA Seeks Increased Authority in 2025 Proposals
  • Executive Order Signed to Advance Women's Health Research and Innovation
  • FDA Publishes Paper on Artificial Intelligence and Medical Products
  • CMS Reopens MIPS EUC Exception Application Window

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More